Literature DB >> 8989166

Lung transplantation for alpha 1-antitrypsin deficiency emphysema.

E P Trulock1.   

Abstract

Lung transplantation is an option for appropriately selected patients with end-stage emphysema caused by alpha 1-antitrypsin deficiency. The functional results have been excellent after single or bilateral lung transplantation, and the medium-term survival results have been good. However, the role of alpha 1-antitrypsin replacement therapy after lung transplantation remains uncertain, and further investigation is needed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989166     DOI: 10.1378/chest.110.6_supplement.284s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Alpha(1)-Antitrypsin Deficiency.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  Null allele alpha-1 antitrypsin deficiency: case report of the total pleural covering technique for disease-associated pneumothorax.

Authors:  Takashi Kusu; Tomoyuki Nakagiri; Masato Minami; Yasushi Shintani; Yoshihisa Kadota; Masayoshi Inoue; Noriyoshi Sawabata; Meinoshin Okumura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-04-28

Review 3.  Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers?

Authors:  M Schwaiblmair; C Vogelmeier
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 3.923

Review 4.  Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes.

Authors:  Sanjay H Chotirmall; Mazen Al-Alawi; Thomas McEnery; Noel G McElvaney
Journal:  Ther Clin Risk Manag       Date:  2015-01-29       Impact factor: 2.423

5.  Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.

Authors:  Irina Petrache; Joud Hajjar; Michael Campos
Journal:  Biologics       Date:  2009-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.